During the past decade, Medical Oncology, LLC conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 11 clinical trials were completed, i.e. on average, 137.5% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 9 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical Oncology, LLC" #1 sponsor was "SWOG Cancer Research Network" with 9 trials, followed by "AVEO Pharmaceuticals, Inc." with 2 trials sponsored, "Point Therapeutics" with 2 trials sponsored, "Alaunos Therapeutics" with 1 trials sponsored and "Astellas Pharma Inc" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Oncology, LLC" #1 collaborator was "National Cancer Institute (NCI)" with 10 trials as a collaborator, "Agensys, Inc." with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Bionomics Limited" with 1 trials as a collaborator and "Eastern Cooperative Oncology Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Medical Oncology, LLC" are "Recurrent Squamous Cell Lung Carcinoma" (5 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (4 trials), "Pancreatic Cancer" (3 trials), "Renal Cell Carcinoma" (2 trials) and "Adenocarcinoma" (1 trials). Many other conditions were trialed in "Medical Oncology, LLC" in a lesser frequency.

Most popular intervention types in "Medical Oncology, LLC" are "Drug" (17 trials), "Other" (7 trials), "Biological" (5 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (7 trials), "Docetaxel" (3 trials), "Durvalumab" (2 trials), "Gemcitabine" (2 trials) and "Tivozanib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Medical Oncology, LLC" are 21 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Medical Oncology, LLC". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Medical Oncology, LLC, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Medical Oncology, LLC, 1 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".